Calzetta, L.; Chetta, A.; Aiello, M.; Frizzelli, A.; Ora, J.; Melis, E.; Facciolo, F.; Ippoliti, L.; Magrini, A.; Rogliani, P.
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines 2023, 11, 282.
https://doi.org/10.3390/vaccines11020282
AMA Style
Calzetta L, Chetta A, Aiello M, Frizzelli A, Ora J, Melis E, Facciolo F, Ippoliti L, Magrini A, Rogliani P.
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines. 2023; 11(2):282.
https://doi.org/10.3390/vaccines11020282
Chicago/Turabian Style
Calzetta, Luigino, Alfredo Chetta, Marina Aiello, Annalisa Frizzelli, Josuel Ora, Enrico Melis, Francesco Facciolo, Lorenzo Ippoliti, Andrea Magrini, and Paola Rogliani.
2023. "The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma" Vaccines 11, no. 2: 282.
https://doi.org/10.3390/vaccines11020282
APA Style
Calzetta, L., Chetta, A., Aiello, M., Frizzelli, A., Ora, J., Melis, E., Facciolo, F., Ippoliti, L., Magrini, A., & Rogliani, P.
(2023). The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines, 11(2), 282.
https://doi.org/10.3390/vaccines11020282
